Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aelis, Astellas, Bioved, Cerevel, Equillium, Krystal, Mimivax, Ocugen, Palisade, Skye, Synaptogenix.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Abcellera, Apotex, Atyr, Axcella, Biocryst, Gri, Immix, Kaleibe, Nexcella, Nimble, Oxford Biomedica, Phoremost, Poolbeg, Praxis, Psyence, Qrons, Qu, Replay, Selecta, Sio, Sumitomo, Teva, Thinkcyte, UCB, Urica, Valbiotis, Vallon, Vanda, Woodward.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinogen, Alto, Avidity, Catalym, Dermaliq, Ellipses, Epicentrx, Imaginab, Geneos, Genprex, Icosavax, Irlab, Kymera, Moonlake, Oxurion, Passage, Precision, Quoin, Recbio, Splisense, Tracon, Ultimovacs.

Additional early-stage research and drug discovery news in brief, from: Dyadic, Nuvalent.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bittium, Quantumdx.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Bioxytran, Eva, Exicure, Harrow Ipsen, Lilly.